Capricor Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	19.51	11.29	14.69	9.6	34.89	32.67
Short-Term Investments	79.06	140.23	24.79	31.82	-	-
Cash & Short-Term Investments	98.57	151.52	39.49	41.42	34.89	32.67
Cash Growth	15.92%	283.70%	-4.67%	18.74%	6.79%	230.45%
Accounts Receivable	0.06	10.37	10.37	0.55	0.39	-
Total Trade Receivables	0.06	10.37	10.37	0.55	0.39	-
Other Current Assets	2.33	1.5	1	0.92	1.16	1.01
Total Current Assets	100.95	163.39	50.86	42.89	36.44	33.68
Net Property, Plant & Equipment	25	6.87	7.61	6.94	4.62	0.85
Other Intangible Assets	-	-	-	-	-	0
Other Long-Term Assets	0.49	0.22	0.27	0.27	0.28	0.09
Total Assets	126.44	170.48	58.73	50.09	41.33	34.62
Accounts Payable	2.72	3.28	6.25	4.92	3.72	2.72
Accrued Expenses	9.93	4.91	-	-	-	-
Short-Term Debt	-	-	-	-	-	0.25
Current Portion of Leases	0.12	0.83	0.75	0.68	0.42	-
Unearned Revenue	12	12	24.27	17.98	-	-
Other Current Liabilities	3.38	-	-	-	-	-
Total Current Liabilities	28.15	21.03	31.27	23.59	4.13	2.97
Long-Term Debt	-	-	-	-	-	0.07
Long-Term Leases	14.42	0.62	1.49	1.88	2.45	-
Other Long-Term Liabilities	-	3.38	3.38	12.84	3.38	3.38
Total Long-Term Liabilities	14.42	3.99	4.86	14.72	5.83	3.45
Total Liabilities	42.57	25.02	36.13	38.31	9.96	6.42
Common Stock	0.05	0.05	0.03	0.03	0.02	0.02
Additional Paid-in Capital	357.68	344.22	181.7	148.74	139.4	116.22
Accumulated Other Comprehensive Income	0.84	1.03	0.24	0.11	-	-
Retained Earnings	-274.71	-199.83	-159.37	-137.08	-108.06	-88.04
Shareholders' Equity	83.87	145.46	22.6	11.79	31.37	28.2
Total Liabilities & Equity	126.44	170.48	58.73	50.09	41.33	34.62
Total Debt	14.54	1.45	2.24	2.56	2.87	0.32
Net Cash (Debt)	84.02	150.06	37.25	38.86	32.01	32.35
Net Cash Growth	-44.01%	302.84%	-4.14%	21.38%	-1.03%	227.23%
Net Cash Per Share	1.85	4.26	1.39	1.58	1.39	2.08
Book Value	83.87	145.46	22.6	11.79	31.37	28.2
Book Value Per Share	1.85	4.13	0.84	0.48	1.36	1.81
Tangible Book Value	83.87	145.46	22.6	11.79	31.37	28.2
Tangible Book Value Per Share	1.85	4.13	0.84	0.48	1.36	1.81

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q